Oman · Delayed Price · Currency is OMR Aerovate Therapeutics Statistics
Total Valuation
MSM:OQGN has a market cap or net worth of OMR 666.92 million. The enterprise value is 980.04 million.
| Market Cap | 666.92M |
| Enterprise Value | 980.04M |
Important Dates
The last earnings date was Monday, July 14, 2025.
| Earnings Date | Jul 14, 2025 |
| Ex-Dividend Date | Mar 27, 2025 |
Share Statistics
MSM:OQGN has 4.33 billion shares outstanding.
| Current Share Class | 4.33B |
| Shares Outstanding | 4.33B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.81% |
| Float | 2.12B |
Valuation Ratios
The trailing PE ratio is 14.66 and the forward PE ratio is 12.94. MSM:OQGN's PEG ratio is 1.70.
| PE Ratio | 14.66 |
| Forward PE | 12.94 |
| PS Ratio | 4.13 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.70 |
Enterprise Valuation
| EV / Earnings | 21.54 |
| EV / Sales | 6.07 |
| EV / EBITDA | 11.59 |
| EV / EBIT | 11.66 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 4.32 |
| Debt / FCF | n/a |
| Interest Coverage | 3.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.34% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 345,743 |
| Profits Per Employee | 97,421 |
| Employee Count | 467 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MSM:OQGN has paid 8.78 million in taxes.
| Income Tax | 8.78M |
| Effective Tax Rate | 16.18% |
Stock Price Statistics
The stock price has increased by +9.22% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +9.22% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 57.76 |
| Average Volume (20 Days) | 14,397,389 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MSM:OQGN had revenue of OMR 161.46 million and earned 45.50 million in profits. Earnings per share was 0.01.
| Revenue | 161.46M |
| Gross Profit | 91.27M |
| Operating Income | 84.03M |
| Pretax Income | 54.28M |
| Net Income | 45.50M |
| EBITDA | 83.74M |
| EBIT | 84.03M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 52.58 million in cash and 365.70 million in debt, giving a net cash position of -313.12 million or -0.07 per share.
| Cash & Cash Equivalents | 52.58M |
| Total Debt | 365.70M |
| Net Cash | -313.12M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | 617.12M |
| Book Value Per Share | 0.14 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 56.53%, with operating and profit margins of 52.04% and 28.18%.
| Gross Margin | 56.53% |
| Operating Margin | 52.04% |
| Pretax Margin | 33.62% |
| Profit Margin | 28.18% |
| EBITDA Margin | 51.87% |
| EBIT Margin | 52.04% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 7.07%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 7.07% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 7.07% |
| Earnings Yield | 6.82% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |